Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategies

Published:2023-11-14 Issue:2 Volume:59 Page:169-175
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Anjie Suzanne I.¹,Hanzel Jurij²,Gecse Krisztina B.¹,D’Haens Geert R.¹,Brandse Johannan F.³

Affiliation:

1. Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands

2. Department of Gastroenterology and Hepatology, Ljubljana University Medical Centre, Ljubljana, Slovenia

3. Department of Gastroenterology and Hepatology, Rijnstate, Arnhem, The Netherlands

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2023.2278424

Reference21 articles.

1. Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease

2. Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

3. Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis

4. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

5. Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis;Digestive Diseases and Sciences;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3